GlaxoSmithKline still has questions to answer over bribery case in China
22nd September 2014
It’s good news that Mark Reilly is not going to prison – but what of GSK chief executive Sir Andrew Witty’s ethical agenda?
Humiliating stuff, especially for a FTSE 100 company whose chief executive, Sir Andrew Witty, preaches an ethical agenda.
But this case was never simply about GSK’s wrongdoings, reputation or the size of the fine.
Read more at source article www.theguardian.com